SYNLAB, Europe’s leading medical diagnostic services provider, and the International Air Transport Association (IATA) announced a partnership to facilitate safe and easy travel. The two partners signed an agreement to incorporate SYNLAB’s extensive lab network into IATA Travel Pass. This will enable airline passengers to access SYNLAB’s broad and secure COVID-19 testing services, benefiting from its international capabilities. SYNLAB and IATA build upon valuable experience gained during a successful pilot project for passenger testing in Columbia over the course of the past months.
IATA Travel Pass allows passengers to locate authorised laboratories at departure locations to get tested for SARS-CoV-2 as required by border and health authorities. After testing, SYNLAB will provide passengers with their certified test results directly through the IATA Travel Pass. The app checks the result against the IATA Travel Pass registry of national entry requirements to produce an “OK to Travel” status. Through the app passengers can share their status and the digital test certificates with authorities and airlines to facilitate travel.
IATA Travel Pass applies the highest data security standards. Authorised laboratories directly send COVID-19 test results to the passenger’s phone as a verifiable credential. This way, the IATA Travel Pass is a digital solution that also prevents potential forgery of test results.
SYNLAB has a proven track record of implementing large-scale SARS-CoV-2 testing concepts: as trusted and long-standing medical partner and advisor to national healthcare systems, governmental entities, international companies, and associations. With its network of more than 450 medical laboratories and over 1,600 sample collection points across 36 countries, SYNLAB is dedicated to offer medical excellence with reliable testing services and shortest possible turnaround times.
